Attitudes Toward Medical and Mental Health Care Delivered Via Telehealth Applications Among Rural and Urban Primary Care Patients

2008 ◽  
Vol 196 (2) ◽  
pp. 166-170 ◽  
Author(s):  
Anouk L. Grubaugh ◽  
Gregory D. Cain ◽  
Jon D. Elhai ◽  
Sarah L. Patrick ◽  
B Christopher Frueh
2006 ◽  
Vol 16 (3) ◽  
pp. 122-132 ◽  
Author(s):  
Kitty S. Chan ◽  
Chloe E. Bird ◽  
Robert Weiss ◽  
Naihua Duan ◽  
Lisa S. Meredith ◽  
...  

2012 ◽  
Vol 136 (3) ◽  
pp. 666-674 ◽  
Author(s):  
W.M. Seekles ◽  
P. Cuijpers ◽  
P. van de Ven ◽  
B.W.J.H. Penninx ◽  
P.F.M. Verhaak ◽  
...  

Author(s):  
Elizabeth R. Pfoh ◽  
Jessica A. Hohman ◽  
Kathleen Alcorn ◽  
Nirav Vakharia ◽  
Michael B. Rothberg

2014 ◽  
Vol 20 (3) ◽  
pp. 241 ◽  
Author(s):  
Victoria J. Palmer ◽  
Caroline L. Johnson ◽  
John S. Furler ◽  
Konstancja Densley ◽  
Maria Potiriadis ◽  
...  

There is a global shift to foster patient-centred and recovery-oriented mental health services. This has resulted from the expansion of how the concept of recovery is understood in mental health literature and practice. Recovery is now more than a return to function or reduction in symptoms; it is a subjective, individualised and multi-faceted experience. To date there has not been investigation of how recovery-oriented services can be translated and implemented into the primary mental health care system. This paper presents the results of a survey from a prospective cohort of primary care patients with probable depression about the importance of written plans to recover. The benefits of having a written plan to recover from depression, as outlined by the participants, were analysed using Leximancer software. The findings provide insights into how written plans may be an important mechanism for implementing a recovery-oriented primary mental health care system. We conclude that the benefits of a written plan provide insight into how patients conceptualise recovery.


SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A294-A294
Author(s):  
Ivan Vargas ◽  
Alexandria Muench ◽  
Mark Seewald ◽  
Cecilia Livesey ◽  
Matthew Press ◽  
...  

Abstract Introduction Past epidemiological research indicates that insomnia and depression are both highly prevalent and tend to co-occur in the general population. The present study further assesses this association by estimating: (1) the concurrence rates of insomnia and depression in outpatients referred by their primary care providers for mental health care; and (2) whether the association between depression and insomnia varies by insomnia subtype (initial, middle, and late). Methods Data were collected from 3,174 patients (mean age=42.7; 74% women; 50% Black) who were referred to the integrated care program for assessment of mental health symptoms (2018–2020). All patients completed an Insomnia Severity Index (ISI) and a Patient Health Questionnaire (PHQ-9) during their evaluations. Total scores for the ISI and PHQ-9 were computed. These scores were used to categorize patients into diagnostic groups for insomnia (no-insomnia [ISI < 8], subthreshold-insomnia [ISI 8–14], and clinically-significant-insomnia [ISI>14]) and depression (no-depression [PHQ-914]). Items 1–3 of the ISI were also used to assess the association between depression and subtypes of insomnia. Results Rates of insomnia were as follows: 34.6% for subthreshold-insomnia, 35.5% for clinically-significant insomnia, and 28.9% for mild-depression and 26.9% for clinically-significant-depression. 92% of patients with clinically significant depression reported at least subthreshold levels of insomnia. While the majority of patients with clinical depression reported having insomnia, the proportion of patients that endorsed these symptoms were comparable across insomnia subtypes (percent by subtype: initial insomnia 63%; middle insomnia 61%; late insomnia 59%). Conclusion According to these data, the proportion of outpatients referred for mental health evaluations that endorse treatable levels of insomnia is very high (approximately 70%). This naturally gives rise to at least two questions: how will such symptomatology be addressed (within primary or specialty care) and what affect might targeted treatment for insomnia have on health were it a focus of treatment in general? Support (if any) Vargas: K23HL141581; Perlis: K24AG055602


2012 ◽  
Vol 63 (12) ◽  
pp. 1247-1251 ◽  
Author(s):  
Nicholas Glozier ◽  
Tracey Davenport ◽  
Ian B. Hickie

Sign in / Sign up

Export Citation Format

Share Document